134 related articles for article (PubMed ID: 22426323)
1. Regulation of human monocarboxylate transporter 4 in skeletal muscle cells: the role of protein kinase C (PKC).
Narumi K; Kobayashi M; Otake S; Furugen A; Takahashi N; Ogura J; Itagaki S; Hirano T; Yamaguchi H; Iseki K
Int J Pharm; 2012 May; 428(1-2):25-32. PubMed ID: 22426323
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the expression and activity of glucose and lactic acid metabolism-related genes by protein kinase C in skeletal muscle cells.
Otake S; Kobayashi M; Narumi K; Sasaki S; Kikutani Y; Furugen A; Watanabe M; Takahashi N; Ogura J; Yamaguchi H; Iseki K
Biol Pharm Bull; 2013; 36(9):1435-9. PubMed ID: 23995654
[TBL] [Abstract][Full Text] [Related]
3. Oxygen tension controls the expression of the monocarboxylate transporter MCT4 in cultured mouse cortical astrocytes via a hypoxia-inducible factor-1α-mediated transcriptional regulation.
Rosafio K; Pellerin L
Glia; 2014 Mar; 62(3):477-90. PubMed ID: 24375723
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia stimulates lactate release and modulates monocarboxylate transporter (MCT1, MCT2, and MCT4) expression in human adipocytes.
Pérez de Heredia F; Wood IS; Trayhurn P
Pflugers Arch; 2010 Feb; 459(3):509-18. PubMed ID: 19876643
[TBL] [Abstract][Full Text] [Related]
5. The effects of different training modalities on monocarboxylate transporters MCT1 and MCT4, hypoxia inducible factor-1α (HIF-1α), and PGC-1α gene expression in rat skeletal muscles.
Ahmadi A; Sheikholeslami-Vatani D; Ghaeeni S; Baazm M
Mol Biol Rep; 2021 Mar; 48(3):2153-2161. PubMed ID: 33625690
[TBL] [Abstract][Full Text] [Related]
6. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism.
Ullah MS; Davies AJ; Halestrap AP
J Biol Chem; 2006 Apr; 281(14):9030-7. PubMed ID: 16452478
[TBL] [Abstract][Full Text] [Related]
7. Cytosolic action of thyroid hormone leads to induction of hypoxia-inducible factor-1alpha and glycolytic genes.
Moeller LC; Dumitrescu AM; Refetoff S
Mol Endocrinol; 2005 Dec; 19(12):2955-63. PubMed ID: 16051672
[TBL] [Abstract][Full Text] [Related]
8. Regulation of monocarboxylate transporter 1 in skeletal muscle cells by intracellular signaling pathways.
Narumi K; Furugen A; Kobayashi M; Otake S; Itagaki S; Iseki K
Biol Pharm Bull; 2010; 33(9):1568-73. PubMed ID: 20823576
[TBL] [Abstract][Full Text] [Related]
9. Monocarboxylate transporter 4, associated with the acidification of synovial fluid, is a novel therapeutic target for inflammatory arthritis.
Fujii W; Kawahito Y; Nagahara H; Kukida Y; Seno T; Yamamoto A; Kohno M; Oda R; Taniguchi D; Fujiwara H; Ejima A; Kishida T; Mazda O; Ashihara E
Arthritis Rheumatol; 2015 Nov; 67(11):2888-96. PubMed ID: 26213210
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of monocarboxylate transporter-4 depletes stem-like glioblastoma cells and inhibits HIF transcriptional response in a lactate-independent manner.
Lim KS; Lim KJ; Price AC; Orr BA; Eberhart CG; Bar EE
Oncogene; 2014 Aug; 33(35):4433-41. PubMed ID: 24077291
[TBL] [Abstract][Full Text] [Related]
11. AMP-activated protein kinase regulates the expression of monocarboxylate transporter 4 in skeletal muscle.
Furugen A; Kobayashi M; Narumi K; Watanabe M; Otake S; Itagaki S; Iseki K
Life Sci; 2011 Jan; 88(3-4):163-8. PubMed ID: 21070787
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase Cdelta mediates insulin-induced glucose transport in primary cultures of rat skeletal muscle.
Braiman L; Alt A; Kuroki T; Ohba M; Bak A; Tennenbaum T; Sampson SR
Mol Endocrinol; 1999 Dec; 13(12):2002-12. PubMed ID: 10598577
[TBL] [Abstract][Full Text] [Related]
13. PKC-dependent stimulation of the human MCT1 promoter involves transcription factor AP2.
Saksena S; Dwivedi A; Gill RK; Singla A; Alrefai WA; Malakooti J; Ramaswamy K; Dudeja PK
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G275-83. PubMed ID: 19033536
[TBL] [Abstract][Full Text] [Related]
14. Involvement of Monocarboxylate Transporter 4 Expression in Statin-Induced Cytotoxicity.
Kikutani Y; Kobayashi M; Konishi T; Sasaki S; Narumi K; Furugen A; Takahashi N; Iseki K
J Pharm Sci; 2016 Apr; 105(4):1544-9. PubMed ID: 26935883
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of statins on human monocarboxylate transporter 4.
Kobayashi M; Otsuka Y; Itagaki S; Hirano T; Iseki K
Int J Pharm; 2006 Jul; 317(1):19-25. PubMed ID: 16621368
[TBL] [Abstract][Full Text] [Related]
16. Nrf2 Activation Enhances Muscular MCT1 Expression and Hypoxic Exercise Capacity.
Wang L; Zhu R; Wang J; Yu S; Wang J; Zhang Y
Med Sci Sports Exerc; 2020 Aug; 52(8):1719-1728. PubMed ID: 32079911
[TBL] [Abstract][Full Text] [Related]
17. Monocarboxylate transporter 4 involves in energy metabolism and drug sensitivity in hypoxia.
Yamaguchi A; Mukai Y; Sakuma T; Narumi K; Furugen A; Yamada Y; Kobayashi M
Sci Rep; 2023 Jan; 13(1):1501. PubMed ID: 36707650
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor activation of the rat PRL promoter is mediated by PKCdelta.
Jackson TA; Schweppe RE; Koterwas DM; Bradford AP
Mol Endocrinol; 2001 Sep; 15(9):1517-28. PubMed ID: 11518800
[TBL] [Abstract][Full Text] [Related]
19. In vivo pH in metabolic-defective Ras-transformed fibroblast tumors: key role of the monocarboxylate transporter, MCT4, for inducing an alkaline intracellular pH.
Chiche J; Le Fur Y; Vilmen C; Frassineti F; Daniel L; Halestrap AP; Cozzone PJ; Pouysségur J; Lutz NW
Int J Cancer; 2012 Apr; 130(7):1511-20. PubMed ID: 21484790
[TBL] [Abstract][Full Text] [Related]
20. The role of monocarboxylate transporter 2 and 4 in the transport of gamma-hydroxybutyric acid in mammalian cells.
Wang Q; Morris ME
Drug Metab Dispos; 2007 Aug; 35(8):1393-9. PubMed ID: 17502341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
